Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | REGN5837 |
Trade Name | |
Synonyms | REGN-5837|REGN 5837 |
Drug Descriptions |
REGN5837 is a bispecific antibody that targets CD28 and CD22, resulting in crosslinking of tumor cells expressing CD22 to T cells expressing CD28, which potentially leads to increased antitumor immune response (PMID: 36350988). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Odronextamab + REGN5837 | Odronextamab REGN5837 | 0 | 1 |
REGN5837 | REGN5837 | 0 | 0 |